Cover Image

Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database

Abstract Background Falls are a common but serious problem in older adults, and may lead to fractures and bleeding. As many factors, such as medication, aging, and comorbid diseases may simultaneously affect fall-related adverse events (AEs) in older adults, we evaluated the association between fall...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haruna Hatahira (Author), Shiori Hasegawa (Author), Sayaka Sasaoka (Author), Yamato Kato (Author), Junko Abe (Author), Yumi Motooka (Author), Akiho Fukuda (Author), Misa Naganuma (Author), Satoshi Nakao (Author), Ririka Mukai (Author), Kazuyo Shimada (Author), Kouseki Hirade (Author), Takeshi Kato (Author), Mitsuhiro Nakamura (Author)
Format:	Book
Published:	BMC, 2018-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report database
by: Satoshi Nakao, et al.
Published: (2021)

Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases
by: Haruna Hatahira, et al.
Published: (2017)

Analysis of patients with hypomagnesemia using the Japanese Adverse Drug Event Report database (JADER)
by: Hiroyuki Tanaka, et al.
Published: (2018)

High-quality reports and their characteristics in the Japanese Adverse Drug Event Report database (JADER)
by: Masami Tsuchiya, et al.
Published: (2021)

Analysis of Drug-Induced Gastrointestinal Obstruction and Perforation Using the Japanese Adverse Drug Event Report Database
by: Riko Satake, et al.
Published: (2021)

A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases
by: Shupeng Zou, et al.
Published: (2024)

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases
by: Qian Liu, et al.
Published: (2024)

Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
by: Ryogo Umetsu, et al.
Published: (2021)

Sarilumab‐induced cutaneous adverse event
by: Sayaka Sato, et al.
Published: (2022)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021)

Adverse Events Following Immunization
by: L.I. Chernyshova
Published: (2014)

Evaluating adverse events in databases
by: Katie Lovell, et al.
Published: (2023)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022)

NURSES' KNOWLEDGE ABOUT ADVERSE EVENTS AND THE CHALLENGES OF REPORTING THESE EVENTS
by: Jamilly Santos Araujo, et al.
Published: (2016)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2022)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024)

Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system
by: Liangxia Li, et al.
Published: (2024)

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system
by: Xianglin Pan, et al.
Published: (2024)

Adverse event signal mining and severe adverse event influencing factor analysis of Lumateperone based on FAERS database
by: Yanjing Zhang, et al.
Published: (2024)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
by: Colleen M. Kingsbury, et al.
Published: (2024)

What Are Adverse Events in Mindfulness Meditation?
by: Dhanesh D. Binda BS, et al.
Published: (2022)

Hospital deaths and adverse events in Brazil
by: Pavão Ana Luiza B, et al.
Published: (2011)

Serious Neurological Adverse Events of Ceftriaxone
by: Clémence Lacroix, et al.
Published: (2021)

ADVERSE EVENTS OF INTERFERONS WITH SYSTEMIC EFFECT
by: A. A. Toporov, et al.
Published: (2018)

Response to "Evaluating Adverse Events in Databases"
by: Fabrizio Calapai, et al.
Published: (2023)

Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019)

ADVERSE EVENTS FOLLOWING IMMUNIZATION OF THE ELDERLY
by: Lúcia Helena Linheira-Bisetto, et al.
Published: (2016)

Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database
by: Keita Oura, et al.
Published: (2024)

Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)
by: Yiwen Bao, et al.
Published: (2024)

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
by: Kaibin Niu, et al.
Published: (2024)

META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports
by: Milena M Murray, et al.
Published: (2023)

Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
by: Yujin Choi, et al.
Published: (2024)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
by: Si Su, et al.
Published: (2023)

Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System
by: Giuseppe Cicala, et al.
Published: (2024)

Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy
by: Hironori Fujii, et al.
Published: (2022)

Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database
by: Shotaro Kobayashi, et al.
Published: (2023)

Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
by: Jing Huang, et al.
Published: (2020)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
by: Pan Ma, et al.
Published: (2022)